TREX1 is an exonuclease that digests DNA in the cytoplasm. Lossof-function mutations of TREX1 are linked to Aicardi-Goutieres Syndrome (AGS) and systemic lupus erythematosus (SLE) in humans.
Trex1
−/− mice exhibit autoimmune and inflammatory phenotypes that are associated with elevated expression of interferon (IFN)-induced genes (ISGs). Cyclic GMP-AMP (cGAMP) synthase (cGAS) is a cytosolic DNA sensor that activates the IFN pathway. Upon binding to DNA, cGAS is activated to catalyze the synthesis of cGAMP, which functions as a second messenger that binds and activates the adaptor protein STING to induce IFNs and other cytokines. Here we show that genetic ablation of cGas in Trex1 −/− mice eliminated all detectable pathological and molecular phenotypes, including ISG induction, autoantibody production, aberrant T-cell activation, and lethality. Even deletion of just one allele of cGas largely rescued the phenotypes of Trex1 −/− mice. Similarly, deletion of cGas in mice lacking DNaseII, a lysosomal enzyme that digests DNA, rescued the lethal autoimmune phenotypes of the DNaseII −/− mice. Through quantitative mass spectrometry, we found that cGAMP accumulated in mouse tissues deficient in Trex1 or DNaseII and that this accumulation was dependent on cGAS. These results demonstrate that cGAS activation causes the autoimmune diseases in Trex1 −/− and DNaseII −/− mice and suggest that inhibition of cGAS may lead to prevention and treatment of some human autoimmune diseases caused by self-DNA.
cGAS | cGAMP | autoimmune disease | Trex1 | DNaseII R ecognition and elimination of invading genetic materials is a fundamental mechanism of host defense. In vertebrate animals, the immune system deploys sensors of DNA and RNA to detect microbial infections (1) (2) (3) . In addition to a subset of Tolllike receptors that detect microbial nucleic acids in the lumen of endosomes, cytosolic nucleic acid sensors also play crucial roles in detecting pathogens, especially those that have successfully breached the membrane barriers and replicated in the interior of a cell. The cytosolic nucleic acid sensors include cyclic GMP-AMP (cGAMP) synthase (cGAS) and retinoic acid inducible gene I (RIG-I)-like receptors, which detect DNA and RNA, respectively, to induce type-I interferons (IFNs) and other inflammatory cytokines (4) (5) (6) . cGAS binds to double-stranded DNA (dsDNA) in a sequence-independent manner (2, 7, 8) . This binding causes a conformational change in the active site of cGAS, which then uses ATP and GTP as the substrates to synthesize cGAMP that contains mixed 2′-5′ and 3′-5′ phosphodiester bonds (9) (10) (11) (12) (13) (14) (15) . cGAMP then binds to and activates the endoplasmic reticulum membrane protein STING (14, (16) (17) (18) . STING in turn activates the protein kinases IKK and TBK1, which activate the transcription factors NF-κB and IRF3, respectively. NF-κB and IRF3 enter the nucleus and function together to induce IFNs and cytokines. RIG-I and its homolog MDA5 detect viral RNA in the cytoplasm and induce IFNs through a similar pathway, except that the essential adaptor protein functioning downstream of RIG-I and its homolog MDA5 is the mitochondrial membrane protein MAVS, not STING (2, 19) .
Although detection of microbial nucleic acids provides a versatile and highly effective mechanism for the immune system to detect infections, inadvertent reactions to self nucleic acids pose a risk of triggering autoimmune and autoinflammatory diseases (20) . In the case of RIG-I, the problem of avoiding activation by cytoplasmic self-RNA is solved by the ability of RIG-I to detect specifically viral RNA that contains 5′-triphosphate and -diphosphate (21) (22) (23) . Cellular RNA contains modifications such as the 5′ cap in mRNA, which usually has 2′-O-methylation at the N1 position that prevents its recognition by RIG-I (24). For cGAS, which can be activated by dsDNA irrespective of its sequence or origin, avoidance of triggering autoimmunity is largely achieved by confining DNA in the nucleus, mitochondria, lysosome, and other membranous compartments, and by degrading DNA in the cytoplasm.
TREX1 is an exonuclease that degrades DNA in the cytoplasm (25) (26) (27) (28) . Trex1 deficiency in humans has been linked to several autoimmune and inflammatory diseases, including Aicardi-Goutieres Syndrome (AGS), systemic lupus erythematosus (SLE), familial chilblain lupus, and retinal vasculopathy with cerebral leukodystrophy (29) . A common feature of these diseases is the elevated expression of IFN-stimulated genes (ISGs), suggesting that a defect in clearing cytosolic DNA leads to the activation of the IFN pathway. Trex1-deficient mice exhibit inflammatory diseases and premature death accompanied by elevated ISG expression. Despite some common autoimmune phenotypes, Trex1 −/− mice manifest myocarditis, whereas human AGS patients suffer severe encephalopathy. The autoimmune and myocarditis phenotypes in Trex1 −/−
Significance
The immune system detects microbial DNA in the cytosol of infected cells and mounts effective antimicrobial responses, including the production of type-I interferons. However, when self-DNA enters or accumulates in the cytosol, it can cause autoimmune diseases. Mutations of the exonuclease Trex1 in humans have been linked to autoimmune diseases including Aicardi-Goutieres Syndrome (AGS) and systemic lupus erythematosus (SLE). In mice, genetic deletion of Trex1 or the lysosomal nuclease DNaseII leads to lethal autoimmune diseases. Here we show that cyclic GMP-AMP synthase (cGAS) activation by self-DNA is responsible for the lethal autoimmune diseases in these models. These results provide the proof-of-concept that inhibition of cGAS may be an effective therapy for some autoimmune diseases such as AGS and SLE. mice are rescued by deleting Sting, supporting an important role of the cytosolic DNA-sensing pathway in causing the inflammatory diseases in the absence of Trex1 (26, 27, 30) . Interestingly, patients with gain-of-function mutations in STING also develop lupus-like syndromes; however, these patients also exhibit unique features of vascular and pulmonary inflammation (31, 32).
Another major cellular nuclease is DNaseII, which is localized in the lysosome and is largely responsible for the clearance of DNA of dead cells and expelled nuclei that are engulfed by macrophages (33) (34) (35) . So far, no known DNaseII deficiency in humans has been reported. DNaseII −/− mice die in utero, and the embryos become severely anemic by embryonic day 17.5 (E17.5), owing to the inability of macrophages to digest nuclear DNA expelled from erythroid precursor cells. The undigested DNA induces excessive production of IFNs, which kill the embryos. Deletion of the IFN receptor IFNAR1 rescued the embryonic lethality of DNaseII −/− mice, but the double-knockout mice developed polyarthritis because of increased production of inflammatory cytokines such as TNF-α and IL6 (36) . The increased production of these cytokines as well as IFNs is dependent on STING, because deletion of Sting in DNaseII −/− mice not only rescued the embryonic lethality but also prevented the development of polyarthritis (37) .
A key question that remains is the identity of the DNA sensor that triggers the autoimmune diseases caused by defective clearance of self-DNA. Although cGAS is the dominant DNA sensor responsible for activating the IFN pathways in response to infections by a variety of pathogens, including DNA viruses, retroviruses, and some bacteria such as Mycobacterium tuberculosis (13, (38) (39) (40) (41) (42) (43) , the role of cGAS in autoimmune diseases has not been extensively investigated. Here we show that deletion of cGas in Trex1 −/− and DNaseII −/− mice rescued the lethal autoimmune phenotypes of these mice and prevented the accumulation of cGAMP and the expression of ISGs in the mutant animals. These results demonstrate that cGAS activation causes the autoimmune diseases in Trex1 −/− and DNaseII −/− mice. −/− mice survived within the same period (Fig. 1A) . Even removal of just one allele of cGas in Trex1 −/− mice allowed ∼93% (91/98) of the mice to survive (Fig. 1) . Hematoxylin and eosin (H&E) staining of the heart, skeletal muscle, skin, and kidney biopsies showed that the inflammatory pathology observed in these tissues of Trex1 −/− mice was eliminated in Trex1 −/− cGas −/− mice and markedly reduced in Trex1 Fig. 2 and Fig. S1 A-E). Moreover, splenomegaly found in Trex1 −/− mice was not observed in Trex1 −/− cGas −/− mice ( Fig. S1 F-H ). These results demonstrate that cGAS is responsible for the inflammation and lethality of Trex1 −/− mice.
cGAS Deletion Abolishes the Expression of ISGs and Inflammatory Cytokines in Trex1
−/− Mice. Gene-expression analysis by quantitative RT-PCR (qRT-PCR) of RNA from the hearts of 12-wk-old Trex1 −/− and Trex1 +/− mice showed that Trex1 −/− mice had elevated levels of ISGs, including IFIT3, CXCL10, and IRF7, as well as the inflammatory cytokines TNF-α and IL-12 ( Fig. S2A and Table S1 ). The expression of these ISGs and cytokines was largely abolished by removing one or both alleles of cGas in Trex1 −/− mice ( Fig. 3 A-E and Fig. S2A ). Similar results were obtained by using kidneys and peripheral blood monocytes (PBMCs; Fig. S2 B and C) or by measurements of IL-12 protein in the mouse sera (Fig. S2D) . Elevated levels of ISGs in bone marrow dendritic cells (BMDCs) (Fig. S3A) , macrophages (Fig. S3B) , and embryonic fibroblasts (Fig. S3C) from Trex1 −/− mice were largely blunted by the deletion of cGas. Quantitative mass spectrometry (MS) was used to measure the absolute amounts of cGAMP in mouse hearts. This measurement was made possible by spiking an internal standard of 13 (Fig. 3F) . Interestingly, the levels of cGAMP in Trex1 −/− Sting −/− mice were approximately eightfold higher than those in Trex1 −/− mice (Fig. 3G) , suggesting that STING facilitates the clearance of cGAMP through an unknown mechanism. Because Trex1 −/− Sting −/− mice do not display any apparent inflammation or other abnormal phenotypes (30), these results imply that high levels of cGAMP do not appear to cause adverse effects in mice in the absence of STING.
cGAS Activation Causes Autoantibody Production and T-Cell Activation in Trex1
−/− Mice. Trex1 −/− mice, both 12-wk-and 5-mo-old, developed autoantibodies against DNA, nuclear antigens (ANAs), and other self-antigens, including histone H3, M2, and the U1 subunit of small nuclear ribonucleoprotein (U1-snRNP; Fig. 4 A-C and Fig. S4 ). All of these autoantibodies were greatly reduced by deleting one or both alleles of cGas. The CD4 and CD8 T cells from Trex1 −/− mice had higher expression of T-bet than T cells from Trex1 mice, had elevated expression of IFN-γ and T-bet (also known as Tbx21) RNA, indicating spontaneous infiltration of activated immune cells to the heart, which was blocked by deleting cGas (Fig. S6) . Autoreactive T cells in Trex1 −/− mice were evident by enhanced surface expression of CD69 for CD4 and CD8 T cells and Ly6c for CD8 T cells (Fig. S7 C- 
E). Deletion of cGas in Trex1
−/− mice markedly reduced the numbers of these activated T cells (Fig. S8 C-E) . (Fig. S9A) . Thus, deletion of both cGas alleles is necessary to rescue the lethality of DNaseII −/− mice. As shown previously, DNaseII
Ifnar1
−/− mice developed polyarthritis and produced antibodies against dsDNA ( Fig. 5; ref. 36 ). In contrast, DNaseII −/− cGas −/− mice did not have apparent signs of arthritis, and the anti-DNA antibody was greatly reduced (Fig. 5 A-C) . These results, together with the previous data showing that deletion of Sting rescued the phenotypes of DNaseII −/− mice, strongly suggest that cGAS is the dominant DNA sensor that activates STING to cause lethal autoimmunity in DNaseII −/− mice. qRT-PCR analyses of RNA isolated from the fetal liver, embryonic limb, and fibroblasts at E15.5 showed that the expression levels of IFIT3, CXCL10, and ISG15 were much higher in DNaseII These results further suggest that cGAS is indispensable for the production of cGAMP in DNase-deficient cells, whereas STING appears to play a role in facilitating the clearance of cGAMP.
Discussion
A number of DNA sensors have been proposed to induce type-I IFNs. Besides cGAS, several other proteins, including DAI, IFI16, DDX41, and DNA-PK, were reported to mediate IFN induction through STING (44) . However, so far, only cGAS has been demonstrated by genetic experiments to function as a nonredundant and essential cytosolic DNA sensor that activates the type-I IFN pathway in vivo (13, 41) . In particular, cGas −/− mice and cells derived from these mice failed to produce IFNs in response to infection by several DNA viruses. TLR9 is a membrane protein localized on the endosomal membrane, with its ligandbinding domain facing the lumen of endosome. TLR9 is activated by certain single-stranded DNA oligos that contain CpG-rich sequences. The binding of CpG DNA to TLR9 in plasmacytoid dendritic cells leads to production of copious amounts of IFN-α. However, induction of IFNs by mammalian DNA in myeloid dendritic cells was shown to be independent of TLR9 (45), and deletion of TLR9 in DNaseII −/− mice failed to rescue the lethal autoimmune diseases of these mice (46) . Thus, another DNA sensor is likely responsible for triggering the inflammatory cascades when cellular DNA clearance is impeded.
Initial evidence that cGAS is responsible for activating the type-I IFN pathway in Trex1 −/− cells was provided by findings that retroviruses such as HIV-1 robustly induced IFNs and ISGs in Trex1-deficient cells and that such induction was abolished by TALENmediated knockout of cGas (39) . Subsequent studies further showed that deletion of cGas by the CRISPR/Cas9 technology in cell lines lacking Trex1 or DNaseII abrogated the induction of several ISGs (47, 48) . In this study, we demonstrated that Trex1 −/− cGas −/− mice were viable and free of any observable signs of diseases that would otherwise cause mortality in Trex1 −/− mice. We further showed that cGas deletion rescued the embryonic lethality of DNaseII −/− mice and that the DNaseII 
Ifnar1
−/− mice. Taken together, these results provide the in vivo proof that cGAS activation is responsible for autoimmune diseases caused by defective clearance of self DNA.
Although the rescue of DNaseII −/− mice requires the deletion of both alleles of cGas, deletion of just one allele of cGas is sufficient to largely eliminate the inflammatory disease and rescue the lethality of Trex1 −/− mice. It is not clear what causes the difference in these two models, but one possibility is that DNaseII −/− cells may contain more DNA in the cytoplasm than Trex1 −/− cells, thereby causing strong inflammatory responses with just one allele of cGas. Alternatively, the cell types responsible for triggering the inflammatory responses may be different between DNaseII −/− and Trex1 −/− mice; hence, the threshold of cGAS expression required to cause autoimmune diseases may vary in different cells. Future research should be directed at determining the cell types responsible for causing the autoimmune diseases in DNaseII −/− and Trex1 −/− mice. Another important direction is to investigate the origin and nature of self-DNA that accumulates in these DNase-deficient mice. Through quantitative MS, we have provided direct evidence that tissues from Trex1 −/− and DNaseII −/− mice contain elevated levels of cGAMP, which explains why the IFN pathway is activated in these mice. Deletion of cGas ablated cGAMP production in these mice, formally demonstrating that cGAS is solely responsible for synthesizing cGAMP in response to accumulation of self-DNA in the cytosol. Interestingly, deletion of Sting further elevated the cGAMP levels in Trex1 −/− and DNaseII −/− mice, suggesting that STING facilitates the clearance of cGAMP. The mechanism by which STING facilitates cGAMP clearance requires further investigation.
The demonstration that cGAS activation is responsible for the severe autoimmune diseases and lethality in Trex1 −/− and DNaseII −/− mice strongly suggests that inhibition of cGAS could provide therapeutic benefits to patients with AGS and other autoimmune diseases such as SLE. cGAS is an enzyme that is likely amenable to inhibition by small-molecule drugs, and the recent determination of the high-resolution structures of cGAS in its apo-and DNA-bound forms should facilitate the development of these inhibitors (9-12, 14, 15, 49, 50) . The patients who are most likely to benefit from cGAS inhibitors are those with elevated cGAMP production. Our finding that cGAMP levels are elevated in Trex1 −/− and DNaseII −/− mice provides a proof of concept for extending such measurements to human patients with a variety of autoimmune diseases, especially those with interferonopathies (exhibiting IFN signatures).
Materials and Methods

Mice. Trex1
+/− mice were from Deborah Barnes (Cancer Research U.K., London)
and Nan Yan (University of Texas Southwestern Medical Center), and DNaseII +/ − mice were from Shigekazu Nagata (Kyoto University, Kyoto). cGas −/− mice were generated in our laboratory as described (13) . All mice used in this study were on C57BL/6 background. The mice were bred and maintained under specific pathogen-free conditions in the animal facility of the University of Texas Southwestern Medical Center at Dallas according to experimental protocols approved by the Institutional Animal Care and Use Committee.
Pathology. Tissues were fixed in 4% (wt/vol) paraformaldehyde, paraffinembedded, cut into 5-μm sections, and stained with H&E. Heart tissues were stained with Picro-Sirius red, and kidney samples were stained with periodic acid-Schiff. Inflammation and fibrosis were evaluated based on degree of severity. The sum of individual scores was used to obtain a total tissue histological score. Specific information about the scoring criteria for each tissue was described (30) . Clinical assessment of foot pads for arthritis was performed as described (36) .
cGAMP Extraction and Quantification. Fresh organs were snap-frozen in liquid nitrogen, minced immediately with dissecting scissors in cold 80% (vol/vol) methanol with 2% (vol/vol) acetic acid (HAc), and stored at −80°C before further processing. On the day of analysis, the frozen samples were thawed on ice, and 13 C 10
15
N 5 -labeled cGAMP (+15 atomic mass units) internal standard was supplemented. Samples were then homogenized with a tissue tearor (Biospec Products) for 30 s and cleared by centrifugation (10,000 × g) for 10 min. The pellets were further extracted in 20% (vol/vol) methanol and 2% HAc for two more rounds, and all of the cleared extracts were combined. From these extracts, cGAMP was enriched by solid-phase extraction (SPE) using HyperSep Aminopropyl SPE Columns (Thermo Scientific). Briefly, the columns were first activated by methanol and washed twice with 2% HAc; after drawing through the extracts, columns were washed twice with 2% HAc and once with 80% methanol and, finally, eluted with 4% (vol/vol) ammonium hydroxide in 80% methanol. The eluents were spin-vacuumed to dryness, reconstituted in liquid chromatography (LC)/MS-grade water, cleared by centrifugation, and transferred to autosampler vials for MS analyses.
MS analyses were performed as described (38) . Briefly, the SPE eluents were separated on an Xbridge Amide column (3.5 μm, 3.5 mm ID × 100 mm L; Waters) on a Dionex Ultimate 3000 Rapid Separation Liquid Chromatography system (Thermo Scientific). Mobile phase A was 20 mM ammonium bicarbonate with 20 mM ammonium hydroxide in water, and mobile phase B was acetonitrile. The separation ran at a flow rate of 400 μL/min for the first 14.5 min and 800 μL/min for the remaining 8.5 min, through the following gradient: 0 min, 85% B; 3 min, 85% B; 10 min, 2% B; 14 min, 2% B; 14.5 min, 85% B; and 23 min, 85% B.
The LC eluent was ionized by an Ion Max NG heated electrospray source, with a spray voltage of +3,750 V; an ion transfer tube temperature of 342°C; a vaporizing temperature of 292°C; and the sheath, auxiliary, and sweep gas at 45, 17, and 1 arbitrary units, respectively. The spray was analyzed online on a TSQ Quantiva triple quadruple mass spectrometer (Thermo Scientific), which performed continuous multiple reaction monitoring scans with a dwell time of 50 ms, Q1 and Q3 resolutions of 0.7 FWHM, and the collisioninduced dissociation gas of 1.5 units. cGAMP and the internal standard were monitored in the positive mode with four transitions, respectively (cGAMP: 675-136, 675-152, 675-476, and 675-524; and the internal standard: 691-146, 691-152, 691-491, and 691-539). Raw MS Data were converted to the mzXML format with ReAdW and read into MATLAB for noise reduction and data processing. Absolute quantities of endogenous cGAMP were calculated with the light:heavy ratios and the molar quantity of supplemented internal standard.
Statistics. Statistical analysis of mouse survival was performed by using the Mantel-Cox test. Other statistical analyses were performed with a twotailed, unpaired Student's t test.
Note. While our manuscript was in submission, Gray et al. independently showed that cGas ablation rescued the autoimmune phenotypes of Trex1 Gao et al.
